22 Oct Bosentan for the treatment of pulmonary arterial hypertension associated with congenital heart disease
Background information of the condition Pulmonary Arterial Hypertension (PAH) is a rare and potentially fatal disorder. It is manifested by dyspnea on exertion, syncope and signs and symptoms of right heart failure. In congenital heart disease...